Trial Profile
A Real Life Study Comparing the Clinical Outcomes of a Novel Everolimus Eluting Platinum Chromium Stent with Abluminal Biodegradable Polymer (SYNERGY) and Other New Generation Drug Eluting Stents (n-DES) in Patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Jul 2018
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Sirolimus; Umirolimus; Zotarolimus
- Indications Coronary artery restenosis
- Focus Adverse reactions; Therapeutic Use
- 31 Jul 2018 New trial record